Corporate Profile for SangStat Medical Corp., dated Oct. 29, 1999.--(BUSINESS WIRE)-- The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: Oct. 29, 1999
Company Name: SangStat Medical Corp.
Address: 6300 Dumbarton Circle
Fremont, CA 94555
Main Telephone
Number: 510/789-4300
Internet Home
Page Address
(URL) www.sangstat.com
Chief Executive
Officer: Jean-Jacques BienaimT
Chief Financial
Officer: Steve Dance (Sr. VP Finance)
Investor Relations
Contact: Therese Crozier
Business number: 510/789-4331
E-mail address: tcrozier@sangstat.com
Public Relations
Contact: Therese Crozier
Business number: 510/789-4331
E-mail address: tcrozier@sangstat.com
Industry: Pharmaceuticals/Biotech
Trading Symbol/
Exchange: SANG/Nasdaq
Company description: SangStat, The Transplant transplant or graft Partial or complete organ or other body part removed from one site and attached at another. It may come from the same or a different person or an animal. One from the same person—most often a skin graft—is not rejected. Company, is a specialty A contract under seal. A specialty is a written document that has been sealed and delivered and is given as security for the payment of a specifically indicated debt. pharmaceutical company applying a disease management approach to improve the outcome of organ transplantation The transfer of organs such as the kidneys, heart, or liver from one body to another. The transplantation of human organs has become a common medical procedure. Typical organs transplanted are the kidneys, heart, liver, pancreas, cornea, skin, bones, and lungs. . The company's devices, drugs and services form a family of products that address the needs of patients in each stage of transplant care from pre-transplant monitoring to lifetime post-transplant care. SangStat's product pipeline is a combination of proprietary and licensed-in products that are in various stages of research, development and marketing. The company plans to capitalize on Cap´i`tal`ize on` v. t. 1. To turn (an opportunity) to one's advantage; to take advantage of (a situation); to profit from; as, to capitalize on an opponent's mistakes s>. this pipeline by developing relationships with key providers and managed care organizations to better integrate the management of transplant recipients' care to improve outcomes and lower costs. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion